- Report
- April 2026
- 160 Pages
Global
From €3004EUR$3,320USD£2,566GBP
€3755EUR$4,150USD£3,208GBP
- Report
- October 2025
- 160 Pages
Global
From €2859EUR$3,160USD£2,443GBP
€3574EUR$3,950USD£3,053GBP
- Report
- December 2025
- 150 Pages
Global
From €4389EUR$4,850USD£3,749GBP
- Report
- October 2025
- 150 Pages
Global
From €4389EUR$4,850USD£3,749GBP
- Report
- August 2025
- 150 Pages
Global
From €4389EUR$4,850USD£3,749GBP
- Report
- September 2025
- 110 Pages
Global
From €3500EUR$4,143USD£3,094GBP
- Report
- October 2025
- 100 Pages
United States
From €5384EUR$5,950USD£4,599GBP
- Report
- August 2025
- 199 Pages
Global
From €3208EUR$3,545USD£2,740GBP
€3564EUR$3,939USD£3,045GBP
- Report
- February 2026
- 250 Pages
Global
From €4063EUR$4,490USD£3,471GBP
- Report
- February 2026
- 250 Pages
Global
From €4063EUR$4,490USD£3,471GBP
- Report
- February 2026
- 250 Pages
Global
From €4063EUR$4,490USD£3,471GBP
- Report
- July 2026
- 278 Pages
Global
From €5294EUR$5,850USD£4,522GBP
- Report
- April 2026
- 180 Pages
Global
From €4298EUR$4,750USD£3,671GBP
- Report
- May 2026
- 294 Pages
Global
From €2262EUR$2,500USD£1,932GBP
- Report
- March 2026
- 170 Pages
Global
From €4389EUR$4,850USD£3,749GBP
- Report
- February 2026
- 260 Pages
Global
From €3269EUR$3,613USD£2,792GBP
€3846EUR$4,250USD£3,285GBP
- Report
- May 2025
- 120 Pages
Global
From €5384EUR$5,950USD£4,599GBP
- Report
- January 2024
- 150 Pages
Global
From €5384EUR$5,950USD£4,599GBP
- Report
- March 2024
- 200 Pages
Global
From €3755EUR$4,150USD£3,208GBP
- Report
- April 2024
- 115 Pages
Global
From €4072EUR$4,500USD£3,478GBP

The Asthma Treatment market is composed of a variety of drugs used to treat asthma symptoms. These drugs are divided into two main categories: long-term control medications and quick-relief medications. Long-term control medications are taken daily to reduce inflammation and prevent asthma symptoms. Quick-relief medications are taken as needed to quickly relieve asthma symptoms. Common long-term control medications include inhaled corticosteroids, leukotriene modifiers, and long-acting beta-agonists. Common quick-relief medications include short-acting beta-agonists and anticholinergics.
The Asthma Treatment market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the market include GlaxoSmithKline, Merck & Co., Novartis, Sanofi, and Teva Pharmaceuticals. Show Less Read more